|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-15
|
$349,322
|
$3,493
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Outpatient Clinic File
|
ZIA CP010126-00580
|
$74,164
|
$3,708
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S3
|
$4,555,705
|
$45,557
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S4
|
$74,854
|
$749
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S5
|
$139,989
|
$1,400
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Using game mechanics to improve outcomes among stem cell transplant survivors
|
1R41CA168107-01
|
$300,000
|
$150,000
|
McLaughlin, Jeffery
|
RADIANT CREATIVE GROUP, LLC
|
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-28
|
$2,138,730
|
$21,387
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-25
|
$1
|
$0
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Understanding T Cell Rapamycin Resistance
|
ZIABC011220
|
$236,816
|
$23,682
|
Fowler, Daniel
|
CCR (NCI)
|
|
|
U10 Full Member Application Affiliated with SWOG
|
5U10CA105409-09
|
$341,201
|
$3,412
|
Kim, Edward
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Transplant cancer match
|
ZIA CP010176-10291
|
$23,528
|
$2,353
|
Engels, Eric
|
DCEG (NCI)
|
|
|
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
|
5R01CA098285-09
|
$501,376
|
$501,376
|
ALT, FREDERICK
|
IMMUNE DISEASE INSTITUTE, INC.
|
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-03
|
$131,854
|
$1,319
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
|
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
|
1R01CA157660-01A1
|
$329,363
|
$164,682
|
KLEIN, ULF
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The Role of Fbxw7 in genetic instability and cancer
|
5R01CA116481-06
|
$345,303
|
$69,061
|
Mao, Jian-Hua
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S3
|
$4,829,857
|
$48,299
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S4
|
$75,000
|
$750
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S5
|
$76,389
|
$764
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
TAS::75 0849::TAS INCREMENTAL FUNDING
|
261200800001E-51
|
$238,204,440
|
$71,032
|
HEIMBROOK, DAVID
|
SAIC-FREDERICK, INC.
|
|
|
SWOG Community Clinical Oncology Program Research Base
|
2U10CA037429-28
|
$1,371,233
|
$13,712
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Survivorship: Mentoring and Bridging Primary Care and Oncology
|
5K05CA160724-02
|
$164,278
|
$82,139
|
Oeffinger, Kevin
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB)
|
3U24CA114766-07S1
|
$499,863
|
$49,986
|
RAMIREZ, NILSA
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
|
Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB)
|
3U24CA114766-07S2
|
$1,488,625
|
$148,863
|
RAMIREZ, NILSA
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
|
Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB)
|
7U24CA114766-07
|
$1,329,162
|
$132,916
|
RAMIREZ, NILSA
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIABC010782
|
$343,957
|
$85,989
|
Tosato, Giovanna
|
CCR (NCI)
|
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIABC011109
|
$76,080
|
$761
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
|
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors
|
ZIABC011105
|
$152,161
|
$1,522
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
|
Studies of Epstein-Barr Virus
|
5R37CA012055-40
|
$445,071
|
$111,268
|
MILLER, I.
|
YALE UNIVERSITY
|
|
|
Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort
|
5R01CA140754-03
|
$561,236
|
$280,618
|
Johnson, Christine C
|
HENRY FORD HEALTH SYSTEM
|
|
|
SPORE in Lymphoma
|
2P50CA126752-06
|
$2,300,000
|
$805,000
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Southwest Oncology Group/University of California, Davis
|
5U10CA046441-25
|
$316,002
|
$3,160
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
|
Southwest Oncology Group U10 Member Site
|
5U10CA014028-39
|
$319,062
|
$3,191
|
FLAHERTY, LAWRENCE
|
WAYNE STATE UNIVERSITY
|
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-33S1
|
$196,749
|
$1,967
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-33
|
$8,923,498
|
$89,235
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
|
5U10CA038926-27
|
$4,606,727
|
$46,067
|
LEBLANC, MICHAEL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
SOUTHWEST ONCOLOGY GROUP CA13612
|
5U10CA013612-39
|
$240,397
|
$2,404
|
MILLER, THOMAS
|
UNIVERSITY OF ARIZONA
|
|
|
Southwest Oncology Group
|
5U10CA046282-25
|
$338,795
|
$3,388
|
STIFF, PATRICK
|
LOYOLA UNIVERSITY CHICAGO
|
|
|
Southwest Oncology Group
|
5U10CA020319-36
|
$284,743
|
$2,847
|
Rivkin, Saul
|
SWEDISH MEDICAL CENTER, FIRST HILL
|
|
|
Southwest Oncology Group
|
5U10CA027057-33
|
$400,987
|
$4,010
|
SCHOTT, ANNE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group
|
5U10CA011083-45
|
$377,652
|
$3,777
|
FRIEDBERG, JONATHAN
|
UNIVERSITY OF ROCHESTER
|
|
|
Southwest Oncology Group
|
5U10CA058882-20
|
$337,375
|
$3,374
|
LENZ, HEINZ JOSEF
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
South Texas Pediatric Minority Based CCOP
|
5U10CA052771-22
|
$426,822
|
$4,268
|
LANGEVIN, ANNE-MARIE
|
UNIV OF TX HSC, SA
|
|
|
Significance and Function of HGAL in Lymphoma
|
5R01CA109335-07
|
$243,175
|
$121,588
|
LOSSOS, IZIDORE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
Signal Transduction Pathways in CD30-positive Lymphomas
|
5R01CA142809-03
|
$310,192
|
$155,096
|
DUCKETT, COLIN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
RF Analysis of hematopoietic malignancies in various radiotherapeutically irradiated cohorts
|
ZIA CP010131-10595
|
$37,763
|
$7,553
|
Little, Mark
|
DCEG (NCI)
|
|
|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$243,698
|
N/A
|
(NCI)
|
|
|
Regulation of RANTES expression in T lymphocytes
|
ZIABC011025
|
$626,150
|
$125,230
|
Krensky, Alan
|
CCR (NCI)
|
|
|
Regulation of Exocytosis from Immune Cells
|
ZIABC011035
|
$222,551
|
$55,638
|
Roche, Paul
|
CCR (NCI)
|
|
|
Regulation of Epstein-Barr Virus Latency
|
5R01CA093606-10
|
$303,328
|
$242,662
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
|
Regulation of Autophagy and Tumorigenesis by Bif-1
|
5R01CA129682-04
|
$312,178
|
$78,045
|
WANG, HONG-GANG
|
PENNSYLVANIA STATE UNIVERSITY
|
|
Total relevant funding to Hodgkins disease for this search: $15,632,170
|
